BRCAA1 Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of BRCAA1 monoclonal antibodies for research focused on understanding BRCAA1 protein function. BRCAA1 monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). BRCAA1, or Breast Cancer Associated Antigen 1, plays a vital role in DNA repair processes, particularly during homologous recombination. BRCAA1 function is essential for maintaining genomic stability and preventing tumorigenesis, making it a key focus in cancer research. Mutations in BRCAA1 have been linked to increased susceptibility to breast and ovarian cancers, highlighting its significance in both basic and translational research. Understanding BRCAA1's molecular mechanisms and interactions can provide valuable insights into cancer development and potential therapeutic strategies. Investigating BRCAA1's role in cell cycle regulation and DNA damage response pathways continues to reveal new aspects of cancer biology. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of cancer mechanisms and contribute to the development of targeted therapies.